Journal Guide

Research in Social and Administrative Pharmacy (RSAP) publishes bi-monthly/six times per year, featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.RSAP strives to become a widely recognized venue for publishing articles that proffer new models to guide existing research, make methodological arguments, or otherwise describe the results of rigorous theory-building research. Papers that translate the results of such research into information useful for practitioners are also welcome. RSAP encourages submission of manuscripts from multi-disciplinary collaborators on projects whose goal is to address medication use policy. RSAP also publishes special thematic issues that will be of interest and benefit to its readers and to the community at large.

All papers published in Results in Pharma Sciences have undergone full peer review and must be:

• Scientifically sound
• In compliance with international research and publishing ethics
• Written in clear, concise and correct English
• A valid, contribution to the existing literature and of educational value to the specific community and readers
• Not previously published material

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/725997/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Editor-in-Chief: Dr. David M. Whitacre Summerfield. NC. USA DMWhitacre@triad.rr.com Editorial Board: M. Fernanda Cavieres University of Valparaíso. Valparaíso. Chile fernanda.cavieres@uv.cl Dr. Charles P. Gerba University of Arizona. Tucson. AZ. USA gerba@email.arizona.edu Dr. John Giesy University of Saskatchewan Saskatoon. Saskatchewan. Canada JGIESY@aol.com Prof. Dr. Otto Hutzinger University of Bayreuth. Grenzweg. Austria Hutzinger-Univ-Bayreuth@aon.at Dr. James B. Knaak Getzville. NY. USA jbknaak@aol.com Dr. James T. Stevens Wake Forest University School of Medicine Winston-Salem. NC. USA jstevens@wfubmc.edu Dr. Ronald S. Tjeerdema University of California. Davis. CA. USA rstjeerdema@ucdavis.edu Dr. Pim de Voogt University of Amsterdam. Amsterdam. The Netherlands pdevoogt@Science.uva.nl Dr. George Ware Tucson. AZ. USA Gware7@aol.

Reviews on Recent Clinical Trials publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on recent clinical trials of major importance. The journal's aim is to publish the highest quality articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics.

To publish original scientific work, divulgation articles, and reviews in the field of Pharmacognosy.

The Revista Brasileira de Plantas Medicinais (RBPM) was launched in October 1998 (v.1, n.1) as a biannual publication until 2003, and was published three times a year in 2004 and 2005. From 2006, it became a quarterly journal, publishing until August/2010 (v.12, n.3, 2010) 582 scientific papers, the majority of which are scientific articles, some reviews and a few preliminary notes. Since 2008, the Journal is also available at CAPES journals (www.periodicos.capes.gov.br) and at the portal of Summaries of Brazilian Journals, in the Multidisciplinary field (http://www.sumarios.org/ revista.asp?idrevista=271&idarea=9).The Revista Brasileira de Plantas Medicinais covers the great areas of multidisciplinary study on medicinal plants, including Plant Anatomy and Morphology; Bioassays; Biotechnology; Genetic Resource Conservation; Ecophysiology; Ethnobotany; Ethnopharmacology; Pharmacognosis; Pharmacology; Plant Physiology; Phytochemistry; Plant Science; Phytotherapy, Food Technology and use of medicinal plants in Veterinary Medicine.Its abbreviated title is Rev. bras. plantas med., which should be used in bibliographies, footnotes and bibliographical references and strips.

Established in 1868, the Canadian Pharmacists Journal is the oldest continuously published periodical in Canada. Our mission is to attract, disseminate and discuss research and contemporary health care issues and link knowledge to practice. Our vision is to become a leading journal for the application of research and knowledge into pharmacy practice. CPJ is published 6 times per year, with the addition of supplements on specific clinical topics. Both original research and review papers pertaining to clinical, social, regulatory, historical and business topics will be considered for publication. News of interest to the profession, opinion pieces and descriptions of innovative practice models are also welcome.

SAR and QSAR in Environmental Research is an international journal welcoming papers on the fundamental and practical aspects of the structure-activity and structure-property relationships in the fields of environmental science, agrochemistry, toxicology, pharmacology and applied chemistry. A unique aspect of the journal is the focus on emerging techniques for the building of SAR and QSAR models in these widely varying fields. The scope of the journal includes, but is not limited to, the topics of topological and physicochemical descriptors, mathematical, statistical and graphical methods for data analysis, computer methods and programs, original applications and comparative studies. In addition to primary scientific papers, the journal contains reviews of books and software and news of conferences. Special issues on topics of current and widespread interest to the SAR and QSAR community will be published from time to time.Discounted society rate available for the QSAR and Modelling Society members.All published research articles in SAR and QSAR in Environmental Research have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two independent expert referees.DisclaimerTaylor & Francis makes every effort to ensure the accuracy of all the information (the "Content") contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

The Saudi Pharmaceutical Journal is published every three months by the Saudi Pharmaceutical Society, with the cooperation of the College of Pharmacy, King Saud University. The Journal accepts high quality articles that conform to its scope and editorial standards. The scope encompasses various disciplines of pharmaceutical sciences and related clinical subjects that are of interest to practicing pharmacists and other health care professionals. The journal will publish original research articles, review articles, short communications, case studies, letters to the editors and book reviews. Abstracts of meetings and symposia will also be considered for publication. All submitted papers are subject to an extensive review by the editorial board and by a panel of international referees.To minimize delays between manuscript submission, decision and publication, authors are requested to follow the "Instructions to authors" found elsewhere in this Journal. Conforming with all the steps listed in that section will facilitate the processing of your manuscript by the Editorial Board.Accredited as a refereed Journal by the Scientific Council of King Saud University, Riyadh, Kingdom of Saudi Arabia.

Scientia Pharmaceutica publishes original research papers, short communications and a limited number of reviews on all fields of pharmaceutical sciences and related areas, as well as on pharmaceutical practice.

In the past decade research into skin pharmacology has developed dramatically with new and promising drugs and therapeutic concepts being introduced regularly. Recent examples include immunosuppressive topicals, and new strategies in the therapy of malignant melanoma and wound healing. New concepts have also been developed in traditional areas of skin therapy and skin care which have led to discussions of issues such as ‘cosmeceuticals’ in the United States, ‘quasi-drugs’ in Japan, and the 6th Amendment of the Cosmetic Regulation in the European Union. There are many open questions which reflect the importance of the subject and the need for a new international scientific forum where they can be discussed in extenso. Dermatologists, pharmaceutical chemists, pharmacologists, toxicologists, and others interested in the subject are invited to contribute to this exciting project and to submit their best research work for publication.

Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application).

The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review.

Steroids is an international journal devoted to original research on all aspects of steroids. Its focus is on both experimental and theoretical studies in chemistry and physiochemistry, biosynthesis, metabolism, molecular biology, physiology, pharmacology, analytical techniques, comparative endocrinology, clinical research, mode of action (including that of related peptides), and the role of steroids on growth and differentiation.Please bookmark this URL: http://www.elsevier.com/locate/steroidsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com